O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.88B
AUM Growth
-$2.53B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
148
New
Increased
Reduced
Closed

Top Buys

1
+$106M
2
+$80.2M
3
+$77.8M
4
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$43.5M
5
SCPH
scPharmaceuticals
SCPH
+$41.2M

Top Sells

1
+$172M
2
+$171M
3
+$127M
4
MRK icon
Merck
MRK
+$105M
5
GILD icon
Gilead Sciences
GILD
+$101M

Sector Composition

1 Healthcare 91.38%
2 Financials 1.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$22.4M 0.28%
1,022,100
+274,856
77
$22.4M 0.28%
2,839,500
+172,000
78
$21.5M 0.27%
836,500
79
$20.5M 0.26%
254,200
-624,800
80
$19.8M 0.25%
174,800
-494,200
81
$18.2M 0.23%
2,834,126
-2,616,455
82
$18.1M 0.23%
61,427
83
$17.7M 0.22%
660,000
84
$15.7M 0.2%
4,246,196
85
$15.7M 0.2%
1,125,900
-983,168
86
$14.8M 0.19%
1,250,396
+583,730
87
$14.7M 0.19%
967,859
88
$14.2M 0.18%
57,850
+6,560
89
$14.2M 0.18%
1,576,190
90
$14M 0.18%
658,160
91
$13.8M 0.17%
1,518,197
92
$13.4M 0.17%
5,000,000
93
$13.2M 0.17%
8,746,583
+33,495
94
$12.9M 0.16%
1,471,500
+391,800
95
$12.9M 0.16%
220,700
96
$12.8M 0.16%
1,914,660
97
$12.8M 0.16%
87,666
98
$11.9M 0.15%
80,093
-12,500
99
$11.8M 0.15%
650,000
100
$10.9M 0.14%
+207,500
2 3
4
5 6